Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.

Epplein M, Nomura AM, Wilkens LR, Henderson BE, Kolonel LN.

Am J Epidemiol. 2009 Aug 15;170(4):507-14. doi: 10.1093/aje/kwp162.

2.

Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.

Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, Abnet CC, Risch HA, Giffen C, Freedman ND, Chow WH, Sadeghi S, Pandeya N, Whiteman DC, Murray LJ, Bernstein L, Gammon MD, Wu AH.

Gastroenterology. 2012 Mar;142(3):442-452.e5; quiz e22-3. doi: 10.1053/j.gastro.2011.11.019.

3.

Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.

Duan L, Wu AH, Sullivan-Halley J, Bernstein L.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):126-34. doi: 10.1158/1055-9965.EPI-07-0664.

4.

Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr, Blot WJ.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):97-102.

5.

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.

Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, Schatzkin A.

Br J Cancer. 2009 Feb 10;100(3):551-7. doi: 10.1038/sj.bjc.6604880.

6.

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ.

Am J Gastroenterol. 2011 Jul;106(7):1340-50. doi: 10.1038/ajg.2011.38.

7.

Prospective study of regular aspirin use and the risk of breast cancer.

Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA.

J Natl Cancer Inst. 1996 Jul 17;88(14):988-93.

PMID:
8667430
8.

Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer.

Anderson KE, Johnson TW, Lazovich D, Folsom AR.

J Natl Cancer Inst. 2002 Aug 7;94(15):1168-71.

PMID:
12165642
9.

Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.

Reeves MJ, Newcomb PA, Trentham-Dietz A, Storer BE, Remington PL.

Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):955-60.

10.

Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.

Vaughan TL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF Jr.

Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):749-56.

11.

Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study.

Steevens J, van den Brandt PA, Goldbohm RA, Schouten LJ.

Gastroenterology. 2010 May;138(5):1704-13. doi: 10.1053/j.gastro.2009.12.004.

PMID:
20006613
12.

Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study.

Friis S, Poulsen AH, Sørensen HT, Tjønneland A, Overvad K, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.

Cancer Causes Control. 2009 Jul;20(5):731-40. doi: 10.1007/s10552-008-9286-7.

PMID:
19122977
13.

Non-steroidal anti-inflammatory drug use and risk of adult leukemia.

Kasum CM, Blair CK, Folsom AR, Ross JA.

Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):534-7.

14.

Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.

Daugherty SE, Pfeiffer RM, Sigurdson AJ, Hayes RB, Leitzmann M, Schatzkin A, Hollenbeck AR, Silverman DT.

Am J Epidemiol. 2011 Apr 1;173(7):721-30. doi: 10.1093/aje/kwq437. Review.

16.

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.

García Rodríguez LA, Varas-Lorenzo C, Maguire A, González-Pérez A.

Circulation. 2004 Jun 22;109(24):3000-6.

17.

Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.

Haag MD, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH.

Arch Intern Med. 2008 Jun 9;168(11):1219-24. doi: 10.1001/archinte.168.11.1219.

PMID:
18541831
18.

Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.

Akre K, Ekström AM, Signorello LB, Hansson LE, Nyrén O.

Br J Cancer. 2001 Apr 6;84(7):965-8.

19.

COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States).

Sansbury LB, Millikan RC, Schroeder JC, North KE, Moorman PG, Keku TO, de Cotret AR, Player J, Sandler RS.

Cancer Causes Control. 2006 Apr;17(3):257-66.

PMID:
16489533
20.

Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction.

Fischer LM, Schlienger RG, Matter CM, Jick H, Meier CR.

Pharmacotherapy. 2005 Apr;25(4):503-10.

PMID:
15977911

Supplemental Content

Support Center